Steven J. Matays

About Steven J. Matays

Steven represents clients on a wide range of US and international tax matters, with a particular emphasis on mergers and acquisitions, spin-offs and other divestitures, complex debt and equity offerings, corporate and partnership restructurings and joint ventures. He additionally advises on the tax aspects of structuring financial instruments and executive compensation.

Steven has been repeatedly selected for inclusion in Chambers USA, Expert Guides’ Guide to the World’s Leading Tax Advisers and Legal 500. He also has been recognized by ITR World Tax and was previously named a Tax “MVP” by Law360.

Recent work

• Cencora (f/k/a AmerisourceBergen) on its $4bn+ acquisition of Retina Consultants of America.
• Sanofi on the separation and exclusive negotiations with CD&R to transfer a 50% controlling stake in Opella, its consumer healthcare business, based on an enterprise value of c.€16 billion.
• Roivant Sciences on its pending $1.2 billion sale of Dermavant to Organon.
• Twenty-First Century Fox on its $71.3 billion sale to the Walt Disney Company and related pre-merger spin-off of certain news, sports and broadcast businesses.
• Sprint (as co-counsel) regarding the regulatory aspects of its $59 billion merger with T-Mobile US.
• Worldpay on its $43 billion merger with FIS.
• Ecolab on the tax-free spin-off of its upstream energy business and $4.4 billion combination with Apergy.
• Rockwell Collins on its $30 billion sale to United Technologies Corporation.
• Viagogo Entertainment on its $4 billion acquisition of StubHub from eBay.
• DST Systems on its $5.4 billion sale to SS&C Technologies.
• American Express Global Business Travel on its $5.3 billion merger with Apollo Strategic Growth Capital.
• Veoneer on its $4.5 billion sale to Qualcomm Incorporated and SSW Partners.
• Ash Grove Cement on its $3.5 billion sale to CRH.
• Pinnacle Entertainment on its $2.8 billion sale to Penn National Gaming.
• Wells Fargo on the $2.1 billion carve-out sale of Wells Fargo Asset Management to GTCR and Reverence Capital Partners.
• Bruce Sherman, as part of an ownership group led by former New York Yankee Derek Jeter, on the $1.2 billion acquisition of Major League Baseball’s Miami Marlins.
• Kelso & Company on its $805 million sale of Physicians Endoscopy to affiliates of UnitedHealth.
• iCapital on its acquisition of SIMON Markets.
• Hewlett Packard Enterprise Company on the tax-free spin-offs of its:
  • enterprise services business and its combination with Computer Sciences.
  • software business and its combination with Micro Focus International.
• Air Products and Chemicals on its:
  • $3.8 billion sale of the performance materials division of its materials technologies segment to Evonik Industries.
  • tax-free spin-off of its materials technologies business into a separate, publicly owned company called Versum Materials.